
Platelet-vessel hemostasis in patients with myocardial infarction depending on allelic variants of genes ACE (I/D) and eNOS (894G>T). Treatment effect
Author(s) -
J. Ursuliak,
Larysa Sydorchuk
Publication year - 2014
Publication title -
bukovinsʹkij medičnij vìsnik
Language(s) - English
Resource type - Journals
eISSN - 2413-0737
pISSN - 1684-7903
DOI - 10.24061/2413-0737.xviii.1.69.2014.32
Subject(s) - hemostasis , enos , myocardial infarction , medicine , platelet , gene , angiotensin converting enzyme , cardiology , allele , genotype , biology , endocrinology , genetics , nitric oxide synthase , nitric oxide , blood pressure
Changes in the platelet-vascular hemostasis influenced by basic treatment of 102 patients with acute myocardial infarction (AMI) depending on allelic variants of genes angiotensin-converting enzyme (ACE, I/D) and endothelial NO-synthase (eNOS, 894G> T) have been analyzed. The dependence of the treatment efficacy on genotypes and haplotypes of the analyzed genes in relation to hemostasis key-chains has been established.